Skip to main content
global • USD

Diabetes Risk Calculator

Estimate your 10-year risk of type 2 diabetes with the validated FINDRISC score used by health services worldwide. 8 questions, instant result, free and private.

Last revised

By Team GlobalCalqulate · About our editorial standards

Help & FAQs

Frequently Asked Questions

Clear answers to common questions to help you use this calculator confidently.

What is the FINDRISC score?

Tap to view the answer

FINDRISC (Finnish Diabetes Risk Score) is a validated 8-question screening tool that estimates your risk of developing type 2 diabetes within 10 years. It was published in Diabetes Care in 2003 (Lindström & Tuomilehto) from a cohort of 4,435 adults followed for a decade, and is used by the International Diabetes Federation and national health services worldwide.

Is this calculator a diabetes diagnosis?

Tap to view the answer

No. FINDRISC is a screening score, not a diagnostic test, and it only covers type 2 diabetes — it doesn't apply to type 1 diabetes or to gestational diabetes, which is screened separately during pregnancy. Diabetes can only be diagnosed with blood tests — fasting glucose, HbA1c, or an oral glucose tolerance test — interpreted by a healthcare professional. A high score means you should get tested, not that you have diabetes.

What FINDRISC score is considered high?

Tap to view the answer

Scores of 15–20 are classed as high risk (about 1 in 3 develop type 2 diabetes within 10 years) and scores above 20 as very high risk (about 1 in 2). At 15 or above, the official guidance is to have your blood glucose measured by a clinician.

Can I lower my diabetes risk score?

Tap to view the answer

Yes — BMI, waist circumference, physical activity, and diet are all modifiable, worth up to 9 points combined. The Diabetes Prevention Program trial showed that losing 5–7% of body weight with regular activity cut progression to type 2 diabetes by 58% in high-risk adults.

Does FINDRISC work for every population?

Tap to view the answer

FINDRISC was validated in a European (Finnish) population. It remains a reasonable first screen elsewhere, but risk can be underestimated in groups that develop type 2 diabetes at lower BMI — including South Asian, East Asian, and some Indigenous populations. If you belong to a higher-risk group, discuss screening with your clinician even with a moderate score.

Need more help? Contact support or email globalcalqulate@gmail.com

We typically reply within 24–48 hours.